Pfizer Repositioning Itself
Several weeks ago there was news that Pfizer, the maker of Lipitor, was buying King Pharmaceutical. The financial analyst commented that they were making this 3.6 billion dollar deal to help off set the predicted decline in income when their blockbuster drug Lipitor goes generic. Well, in addition to this multi-billion dollar cash purchase, …